Company: TEAM
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001650372-25-000022
Chunk: 6

Company: Atlassian Corp
Filing Date: 2025-05-02
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
 expenses and other liabilities131,508 67,149 53,804 54,958 Deferred revenue171,958 301,681 253,467 393,135 Net cash provided by operating activities652,681 565,390 1,085,078 1,021,940 Cash flows from investing activities:Business combinations, net of cash acquired(994)— (5,969)(844,727)Purchases of property and equipment(14,366)(10,520)(29,853)(19,522)Purchases of strategic investments(1,100)(4,250)(26,650)(8,250)Purchases of marketable securities(116,716)(74,544)(277,039)(213,690)Proceeds from maturities of marketable securities53,584 63,000 125,212 79,150 Proceeds from sales of marketable securities and strategic investments2,622 — 6,935 61,392 Net cash used in investing activities(76,970)(26,314)(207,364)(945,647)Cash flows from financing activities:Principal payments of term loan facility— (12,500)— (25,000)Repurchases of Class A Common Stock(134,305)(35,377)(387,156)(203,029)Other— — (3,143)— Net cash used in financing activities(134,305)(47,877)(390,299)(228,029)Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash1,783 (2,769)(3,709)(1,986)Net increase (decrease) in cash, cash equivalents, and restricted cash443,189 488,430 483,706 (153,722)Cash, cash equivalents, and restricted cash at beginning of period2,218,639 1,461,763 2,178,122 2,103,915 Cash, cash equivalents, and restricted cash at end of period$2,661,828 $1,950,193 $2,661,828 $1,950,193 Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:Cash and cash equivalents$2,660,859 $1,948,978 $2,660,859 $1